Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Analysts Are Bullish On These 5 Stocks That Went Public This Year

RRR, ATKR, USFD, KA

Out of all the stocks that went public in 2016, these five are the ones that analysts are most interested in.

US Foods Holding Corp (NYSE: USFD)

There have been 20 analyst ratings since US Foods went public at $23 on May 26. The stock has been very volatile and is trading around $23.80 as we near the middle of August.

The Stockal Confidence Meter is 64 percent bullish on the company.

Atkore International Group Inc (NYSE: ATKR)

Since Atkore International went public on June 10 at $16, there have been 13 analyst ratings on the company. The stock has been highly volatile and has traded up 9.75 percent since going public.

The Stockal Confidence Meter is 90 percent bullish on Atkore International.

Red Rock Resorts Inc (NASDAQ: RRR)

Red Rock Resorts went public at $19.50 on April 27, and the stock has been rated by analysts 14 times since then. The stock han't  been very volatile since Red Rock Resorts’ IPO, but the company has traded up and sits currently around $22.

The Stockal Confidence Meter is 90 percent bullish on the stock.

Proteostasis Therapeutics Inc (NASDAQ: PTI)

Analysts have rated Proteostasis Therapeutics 10 times since the company went public at $8 on February 11. It has been a volatile stock, and the company is trading around $13.30.

The Stockal Confidence Meter is 87 percent bullish on Proteostasis Therapeutics.

AveXis Inc (NASDAQ: AVXS)

AveXis released its IPO on February 11 at $20, and the stock has seen 11 analyst ratings since. It’s been a very volatile stock and has traded up to $41.30 since it went public.

The Stockal Confidence Meter is 84 percent bullish on the company.